Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
NEUROBIOLOGICAL TECHNOLOGIES INC (NTII)
|
Add to portfolio |
|
|
|
| Price: |
$0.00
| | Metrics |
| OS: |
26.9
|
M
| |
28
|
% ROE
|
| Market cap: |
|
| |
59
|
% ROIC
|
|
Net cash:
|
$26.5
|
M
| |
$0.98
|
per share
|
|
EV:
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$11.9
|
M
| |
-2.2
|
x EV/EBITDA
|
|
EBIT
|
$11.9
|
M
| |
-2.2
|
x EV/EBIT
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-17-09 | Jun-30-09 | Jun-30-08 | Jun-30-07 | Jun-30-06 | Jun-30-05 | Jun-30-04 | Jun-30-03 |
| Revenues | 6.0 | 26.4 | 14.8 | 17.7 | 12.3 | 3.1 | 2.8 | 2.0 |
| Revenue growth | | 78.5% | -16.5% | 43.2% | 298.1% | 11.2% | 40.8% | |
| Cost of goods sold | 0.0 | 17.8 | 24.6 | 26.7 | 22.8 | 10.7 | 2.1 | 2.3 |
| Gross profit | 6.0 | 8.6 | -9.8 | -9.1 | -10.5 | -7.6 | 0.7 | -0.3 |
| Gross margin | 99.4% | 32.5% | -66.5% | -51.3% | -84.8% | -246.8% | 24.7% | -17.0% |
| General and administrative | 1.5 | 5.1 | 6.9 | 6.5 | 6.0 | 4.9 | 3.1 | 2.5 |
| EBIT | 4.5 | 3.5 | -16.7 | -15.6 | -16.4 | -12.6 | -2.4 | -2.8 |
| EBIT margin | 73.9% | 13.2% | -113.1% | -88.3% | -133.2% | -405.8% | -86.6% | -143.0% |
| Pre-tax income | 5.0 | 3.1 | -16.3 | 0.0 | -27.5 | -25.0 | -1.8 | -2.7 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | | | 0.0% | 0.0% | 0.0% |
| Net income | 0.0 | 0.0 | 0.0 | 0.0 | -27.8 | -25.0 | -1.8 | -2.7 |
| Net margin | 0.0% | 0.0% | 0.0% | 0.0% | -225.6% | -805.9% | -64.9% | -135.7% |
| |
| Diluted EPS | | | | | ($6.84) | ($0.94) | ($0.09) | ($0.15) |
| Shares outstanding (diluted) | | | | | 4.1 | 26.6 | 20.1 | 17.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|